Recent advances towards mass spectrometry-based clinical lipidomics

Samira Salihovic, Santosh Lamichane, Tuulia Hyötyläinen, Matej Orešič*

*Korresponderande författare för detta arbete

Forskningsoutput: TidskriftsbidragÖversiktsartikelPeer review

2 Citeringar (Scopus)
5 Nedladdningar (Pure)

Sammanfattning

The objective of this review is to provide a comprehensive summary of the latest methodological advancements and emerging patterns in utilizing lipidomics in clinical research.In this review, we assess the recent advancements in lipidomics methodologies that exhibit high levels of selectivity and sensitivity, capable of generating numerous molecular lipid species from limited quantities of biological matrices.

The reviewed studies demonstrate that molecular lipid signatures offer new opportunities for precision medicine by providing sensitive diagnostic tools for disease prediction and monitoring. Moreover, the latest innovations in microsampling techniques have the potential to make a substantial contribution to clinical lipidomics. The review also shows that more work is needed to harmonize results across diverse lipidomics platforms and avoid significant errors in analysis and reporting. The increased implementation of internal standards and standard reference materials in analytical workflows will aid in this direction.
OriginalspråkEngelska
Artikelnummer102370
Antal sidor9
TidskriftCurrent Opinion in Chemical Biology
Volym76
DOI
StatusPublicerad - okt. 2023
MoE-publikationstypA2 Granska artikel i en vetenskaplig tidskrift

Nyckelord

  • Biomarkers
  • Human health
  • Lipidomics
  • Mass spectrometry
  • Microsampling

Fingeravtryck

Fördjupa i forskningsämnen för ”Recent advances towards mass spectrometry-based clinical lipidomics”. Tillsammans bildar de ett unikt fingeravtryck.

Citera det här